New England Private Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,496
| Closed | -$294K | – | 145 |
|
|
2024
Q3 | $294K | Hold |
11,496
| – | – | 0.05% | 122 |
|
|
2024
Q2 | $270K | Sell |
11,496
-81
| -0.7% | -$1.9K | 0.05% | 121 |
|
|
2024
Q1 | $328K | Hold |
11,577
| – | – | 0.06% | 112 |
|
|
2023
Q4 | $380K | Buy |
11,577
+81
| +0.7% | +$2.66K | 0.07% | 101 |
|
|
2023
Q3 | $320K | Hold |
11,496
| – | – | 0.07% | 94 |
|
|
2023
Q2 | $392K | Hold |
11,496
| – | – | 0.08% | 83 |
|
|
2023
Q1 | $346K | Hold |
11,496
| – | – | 0.07% | 90 |
|
|
2022
Q4 | $325K | Sell |
11,496
-112
| -1% | -$3.16K | 0.07% | 86 |
|
|
2022
Q3 | $382K | Sell |
11,608
-231
| -2% | -$7.6K | 0.09% | 74 |
|
|
2022
Q2 | $545K | Hold |
11,839
| – | – | 0.1% | 75 |
|
|
2022
Q1 | $545K | Buy |
11,839
+72
| +0.6% | +$3.31K | 0.1% | 75 |
|
|
2021
Q4 | $720K | Buy |
11,767
+11
| +0.1% | +$673 | 0.13% | 64 |
|
|
2021
Q3 | $878K | Sell |
11,756
-11
| -0.1% | -$822 | 0.16% | 59 |
|
|
2021
Q2 | $1.09M | Buy |
11,767
+112
| +1% | +$10.4K | 0.21% | 57 |
|
|
2021
Q1 | $1.04M | Buy |
11,655
+342
| +3% | +$30.4K | 0.18% | 58 |
|
|
2020
Q4 | $1.06M | Buy |
11,313
+7
| +0.1% | +$653 | 0.23% | 53 |
|
|
2020
Q3 | $720K | Hold |
11,306
| – | – | 0.18% | 55 |
|
|
2020
Q2 | $601K | Buy |
+11,306
| New | +$601K | 0.16% | 55 |
|